Heranba Industries Ltd vs Mahamaya Lifesciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Heranba Industries Ltd is ₹ 217.95 as of 05 May 15:30 . The P/E Ratio of Heranba Industries Ltd changed from 10.7 on March 2023 to 0 on March 2022 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Mahamaya Lifesciences Ltd changed from 0 on March 2023 to 0 on March 2022 . This represents a CAGR of 0.0% over 4 years The Market Cap of Heranba Industries Ltd changed from ₹ 1117 crore on March 2023 to ₹ 0 crore on March 2022 . This represents a CAGR of -100.00% over 4 yearsThe Market Cap of Mahamaya Lifesciences Ltd changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2022 . This represents a CAGR of 0.0% over 4 years The revenue of Heranba Industries Ltd for the Dec '25 is ₹ 305.17 crore as compare to the Sep '25 revenue of ₹ 518.59 crore. This represent the decline of -41.15% The revenue of Mahamaya Lifesciences Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Heranba Industries Ltd for the Dec '25 is ₹ 16.23 crore as compare to the Sep '25 ebitda of ₹ 45.72 crore. This represent the decline of -64.5% The ebitda of Mahamaya Lifesciences Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Heranba Industries Ltd changed from ₹ 16.62 crore to ₹ -23.44 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Mahamaya Lifesciences Ltd changed from ₹ 5.53 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of -100.00% The Dividend Payout of Heranba Industries Ltd changed from 4.41 % on March 2021 to 7.41 % on March 2025 . This represents a CAGR of 10.94% over 5 yearsThe Dividend Payout of Mahamaya Lifesciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Heranba Industries Ltd

Incorporated in 1992, Heranba Industries Limited is engaged in manufacturing and sale of agro chemical products.
The Company produces synthetic Phrethroids and its intermediates.
Presently, the Company provides processing services for Ammonolysis, Esterification, Hydrolysis, Condensation, Favorski Reaction, Isomerisation, Cyanation, Friedel Crafts, Methoxylation, Cyclisation, Halogenation, Sulphonation etc. Heranba has fully integrated and modern manufacturing facilities with an In-house R&D facility for product development and process intensification.
The company's manufacturing facilities are situated in the industrial belt of Vapi, Gujarat.
The company has an aggregate manufacturing capacity of 14024 MTPA. These facilities offer a range of Crop Protection and Public Health Solutions.

About Mahamaya Lifesciences Ltd

Mahamaya Lifesciences Limited was originally incorporated as a private limited Company as 'Mahamaya Life Sciences Private Limited' by the Assistant Registrar of Companies, NCT Delhi & Haryana, on May 07, 2002.
Further, Company's name was changed from 'Mahamaya Life Sciences Private Limited' to 'Mahamaya Lifesciences Private Limited' dated February 15, 2016.
The status was changed to Public Limited Company on November 19, 2024 by the Central Processing Centre. The Company specializes in manufacturing of pesticide formulations and supply bulk formulations catering to both Indian agrochemical companies, as well as multinational corporations (MNCs).
The Company began the journey by focusing on import and registration of vital pesticide molecules.
It imported these molecules and worked on registering them with the Central Insecticides Board and Registration Committee (CIBRC) under the Department of Agriculture, Government of India.

FAQs for the comparison of Heranba Industries Ltd and Mahamaya Lifesciences Ltd

Which company has a larger market capitalization, Heranba Industries Ltd or Mahamaya Lifesciences Ltd?

Market cap of Heranba Industries Ltd is 872 Cr while Market cap of Mahamaya Lifesciences Ltd is 444 Cr

What are the key factors driving the stock performance of Heranba Industries Ltd and Mahamaya Lifesciences Ltd?

The stock performance of Heranba Industries Ltd and Mahamaya Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Heranba Industries Ltd and Mahamaya Lifesciences Ltd?

As of May 5, 2026, the Heranba Industries Ltd stock price is INR ₹217.95. On the other hand, Mahamaya Lifesciences Ltd stock price is INR ₹190.1.

How do dividend payouts of Heranba Industries Ltd and Mahamaya Lifesciences Ltd compare?

To compare the dividend payouts of Heranba Industries Ltd and Mahamaya Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.